Table 1

Clinical data of patients with IGF-1Rabsent and IGF-1Rpresent MMCs and of patients with IL-6Rlow and IL-6Rhigh MMCs

CategoryIGF-1R, % of patients in each group
IL-6R, % of patients in each group
IGF-1Rabsent (n = 118), %IGF-1Rpresent (n = 53), %IL-6Rlow (n = 85), %IL-6Rhigh (n = 85), %
Age ≥ 65 y 26 21 26 24 
Kappa light chain 64 64 63 65 
Lambda light chain 33 34 36 32 
Nonsecreting 
B2M ≤ 3.5 mg/mL 60 58 63 56 
B2M > 5.5 mg/mL 17 17 19 15 
IgA subtype 20* 33* 15* 33* 
LDH ≥ 240 IU/L 26* 12* 24 19 
Albumin < 35 g/L 37 36 44 31 
Hemoglobin < 10 g/dL 31 32 29 34 
C-reactive protein ≥ 5 mg/L 40 40 43 38 
Bone lesions 
    0, normal bone structure 18 27 21 22 
    1, osteopenia/osteoporosis 28 25 22 33 
    2, osteolyse (1–3) 10 
    3, major structural damage (>3) 46 38 48 36 
CategoryIGF-1R, % of patients in each group
IL-6R, % of patients in each group
IGF-1Rabsent (n = 118), %IGF-1Rpresent (n = 53), %IL-6Rlow (n = 85), %IL-6Rhigh (n = 85), %
Age ≥ 65 y 26 21 26 24 
Kappa light chain 64 64 63 65 
Lambda light chain 33 34 36 32 
Nonsecreting 
B2M ≤ 3.5 mg/mL 60 58 63 56 
B2M > 5.5 mg/mL 17 17 19 15 
IgA subtype 20* 33* 15* 33* 
LDH ≥ 240 IU/L 26* 12* 24 19 
Albumin < 35 g/L 37 36 44 31 
Hemoglobin < 10 g/dL 31 32 29 34 
C-reactive protein ≥ 5 mg/L 40 40 43 38 
Bone lesions 
    0, normal bone structure 18 27 21 22 
    1, osteopenia/osteoporosis 28 25 22 33 
    2, osteolyse (1–3) 10 
    3, major structural damage (>3) 46 38 48 36 

The 171 previously untreated patients with MM were treated at the university hospitals of Heidelberg or Montpellier. Patients were separated into 2 groups: patients with IGF-1Rabsent MMCs and patients with IGF-1Rpresent MMCs or patients with IL-6Rlow MMCs and IL6Rhigh MMCs, as assayed with Affymetrix microarrays. Data are the percentages of patients within these 2 groups with the indicated clinical or biologic parameters.

B2M indicates β2-microglobulin; and LDH, lactate dehydrogenase.

*

The percentages were different with a χ2 test (P ≤ .05).

or Create an Account

Close Modal
Close Modal